irinotecan hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
28 FDA-registered drug labelers
Actavis Pharma, Inc.
Apotex Corp.
Armas Pharmaceuticals Inc.
BluePoint Laboratories
Emcure Pharmaceuticals Limited
Eugia US LLC
Fermion Oy
Fresenius Kabi USA, LLC
Gland Pharma Limited
Hetero Labs Limited
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Hubei Haosun Pharmaceutical Co., Ltd.
Ingenus Pharmaceuticals, LLC
Ipsen Biopharmaceuticals, Inc.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Laurus Labs Limited
Northstar Rx LLC
Olon SpA
Pharmacia & Upjohn Company LLC
Qilu Pharmaceutical Co., Ltd.
Sagent Pharmaceuticals
ScinoPharm Taiwan Ltd.
Shandong Anxin Pharmaceutical Co., Ltd.
SHILPA PHARMA LIFESCIENCES LIMITED
Sichuan Xieli Pharmaceutical Co., Ltd.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Xiromed LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 6 drug and cosmetic product listings (FDA).
- •Irinotecan Hydrochloride
- •Camptosar
- •Irinotecan Hydrochloride 100 mg/5 mL
- •Irinotecan Hydrochloride 40 mg/2 mL
- •Irinotecan hydrochloide
- •Onivyde
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Irinotecan Hydrochloride Injection
09/26/2025to be discontinued
Irinotecan Hydrochloride Injection
08/04/2025to be discontinued
Irinotecan Hydrochloride Injection
02/24/2026Chemical Identity
CAS100286-90-6
PubChem CID74990
DTXSIDDTXSID6045953
FormulaC33H39ClN4O6
Mol. Weight623.1 g/mol
SMILESCCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl
Data Sources
749902026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/irinotecan hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/irinotecan hydrochloride.json
CAS 100286-90-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 100286-90-62026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json